128 related articles for article (PubMed ID: 26219756)
1. High prevalence of late adverse events in malignant bone tumour survivors diagnosed at adult age.
van de Luijtgaarden AC; Kapusta L; Bellersen L; Bokkerink JP; Kaal SE; Versleijen-Jonkers YM; Schreuder HW; van der Graaf WT
Neth J Med; 2014 Dec; 72(10):516-22. PubMed ID: 26219756
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study.
Marina NM; Liu Q; Donaldson SS; Sklar CA; Armstrong GT; Oeffinger KC; Leisenring WM; Ginsberg JP; Henderson TO; Neglia JP; Stovall MA; Yasui Y; Randall RL; Geller DS; Robison LL; Ness KK
Cancer; 2017 Jul; 123(13):2551-2560. PubMed ID: 28222219
[TBL] [Abstract][Full Text] [Related]
3. Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort.
Goldsby R; Burke C; Nagarajan R; Zhou T; Chen Z; Marina N; Friedman D; Neglia J; Chuba P; Bhatia S
Cancer; 2008 Nov; 113(9):2597-604. PubMed ID: 18823030
[TBL] [Abstract][Full Text] [Related]
4. Cumulative Burden of Chronic Health Conditions in Adult Survivors of Osteosarcoma and Ewing Sarcoma: A Report from the St. Jude Lifetime Cohort Study.
Bishop MW; Ness KK; Li C; Liu W; Srivastava DK; Chemaitilly W; Krull KR; Green DM; Pappo AS; Robison LL; Hudson MM; Mulrooney DA
Cancer Epidemiol Biomarkers Prev; 2020 Aug; 29(8):1627-1638. PubMed ID: 32499311
[TBL] [Abstract][Full Text] [Related]
5. Young age at diagnosis, male sex, and decreased lean mass are risk factors of osteoporosis in long-term survivors of osteosarcoma.
Lim JS; Kim DH; Lee JA; Kim DH; Cho J; Cho WH; Lee SY; Jeon DG
J Pediatr Hematol Oncol; 2013 Jan; 35(1):54-60. PubMed ID: 23128330
[TBL] [Abstract][Full Text] [Related]
6. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer.
Geenen MM; Cardous-Ubbink MC; Kremer LC; van den Bos C; van der Pal HJ; Heinen RC; Jaspers MW; Koning CC; Oldenburger F; Langeveld NE; Hart AA; Bakker PJ; Caron HN; van Leeuwen FE
JAMA; 2007 Jun; 297(24):2705-15. PubMed ID: 17595271
[TBL] [Abstract][Full Text] [Related]
7. Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: the Italian Sarcoma Group Experience (1983-2006).
Longhi A; Ferrari S; Tamburini A; Luksch R; Fagioli F; Bacci G; Ferrari C
Cancer; 2012 Oct; 118(20):5050-9. PubMed ID: 22415578
[TBL] [Abstract][Full Text] [Related]
8. Health status at long-term follow-up in patients treated for extremity localized Ewing Sarcoma or osteosarcoma: a Scandinavian sarcoma group study.
Aksnes LH; Bauer HC; Dahl AA; Fosså SD; Hjorth L; Jebsen N; Lernedal H; Hall KS
Pediatr Blood Cancer; 2009 Jul; 53(1):84-9. PubMed ID: 19343771
[TBL] [Abstract][Full Text] [Related]
9. Nutritional status of children and young adults with Ewing sarcoma or osteosarcoma at diagnosis and during multimodality therapy.
Tenardi RD; Frühwald MC; Jürgens H; Hertroijs D; Bauer J
Pediatr Blood Cancer; 2012 Oct; 59(4):621-6. PubMed ID: 22147309
[TBL] [Abstract][Full Text] [Related]
10. Late effects of therapy in adult survivors of osteosarcoma and Ewing's sarcoma.
Nicholson HS; Mulvihill JJ; Byrne J
Med Pediatr Oncol; 1992; 20(1):6-12. PubMed ID: 1727214
[TBL] [Abstract][Full Text] [Related]
11. Shared care by paediatric oncologists and family doctors for long-term follow-up of adult childhood cancer survivors: a pilot study.
Blaauwbroek R; Tuinier W; Meyboom-de Jong B; Kamps WA; Postma A
Lancet Oncol; 2008 Mar; 9(3):232-8. PubMed ID: 18282804
[TBL] [Abstract][Full Text] [Related]
12. High risk of symptomatic cardiac events in childhood cancer survivors.
van der Pal HJ; van Dalen EC; van Delden E; van Dijk IW; Kok WE; Geskus RB; Sieswerda E; Oldenburger F; Koning CC; van Leeuwen FE; Caron HN; Kremer LC
J Clin Oncol; 2012 May; 30(13):1429-37. PubMed ID: 22473161
[TBL] [Abstract][Full Text] [Related]
13. Subsequent primary neoplasms among bone sarcoma survivors; increased risks remain after 30 years of follow-up and in the latest treatment era, a nationwide population-based study.
Hesla AC; Discacciati A; Tsagkozis P; Smedby KE
Br J Cancer; 2020 Apr; 122(8):1242-1249. PubMed ID: 32066914
[TBL] [Abstract][Full Text] [Related]
14. Prospective multicenter registration of major late sequelae in sarcoma patients using the Late Effects Surveillance System (LESS).
Langer T; Stöhr W; Paulides M; Kremers A; Dörr HG; Göbel U; Beck JD
Klin Padiatr; 2005; 217(3):176-81. PubMed ID: 15858710
[TBL] [Abstract][Full Text] [Related]
15. Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting.
Oeffinger KC; Eshelman DA; Tomlinson GE; Buchanan GR; Foster BM
Cancer; 2000 Apr; 88(7):1687-95. PubMed ID: 10738228
[TBL] [Abstract][Full Text] [Related]
16. Health related quality of life and late side effects of long-term survivors of Ewing's sarcoma of bone.
Lopez-Guerra JL; Marquez-Vega C; Praena-Fernandez JM; Ramirez-Villar GL; Ordonez R; Cabrera P; Ortiz MJ
J BUON; 2011; 16(3):528-36. PubMed ID: 22006761
[TBL] [Abstract][Full Text] [Related]
17. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
18. Severe gonadotoxic insult manifests early in young girls treated for Ewing sarcoma.
Mörse H; Elfving M; Turkiewicz A; Andersen CY; Øra I
Medicine (Baltimore); 2016 Aug; 95(33):e4512. PubMed ID: 27537574
[TBL] [Abstract][Full Text] [Related]
19. Patient-reported neurocognitive function in adult survivors of childhood and adolescent osteosarcoma and Ewing sarcoma.
Kadan-Lottick NS; Zheng DJ; Wang M; Bishop MW; Srivastava DK; Ross WL; Rodwin RL; Ness KK; Gibson TM; Spunt SL; Okcu MF; Leisenring WM; Robison LL; Armstrong GT; Krull KR
J Cancer Surviv; 2023 Aug; 17(4):1238-1250. PubMed ID: 35059962
[TBL] [Abstract][Full Text] [Related]
20. Severity of health conditions identified in a pediatric cancer survivor program.
Wasilewski-Masker K; Mertens AC; Patterson B; Meacham LR
Pediatr Blood Cancer; 2010 Jul; 54(7):976-82. PubMed ID: 20108334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
